BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 24372433)

  • 1. [Drug resistance proteins LRP, Pgp, MRP1, MRP3 and MRP5 in ovarian cancer patients].
    Sedláková I; Laco J; Tošner J; Spaček J; Cermáková E
    Ceska Gynekol; 2013 Dec; 78(6):545-53. PubMed ID: 24372433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of the resistance proteins LRP, Pgp, MRP1, MRP3, and MRP5 in epithelial ovarian cancer.
    Sedláková I; Laco J; Caltová K; Červinka M; Tošner J; Řezáč A; Špaček J
    Int J Gynecol Cancer; 2015 Feb; 25(2):236-43. PubMed ID: 25594141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognostic significance of Pgp, MRP1, and MRP3 in ovarian cancer patients].
    Sedláková I; Laco J; Tošner J; Špaček J
    Ceska Gynekol; 2015 Dec; 80(6):405-13. PubMed ID: 26741154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Proteins of resistance and drug resistance in ovarian carcinoma patients].
    Sedláková I; Laco J; Tošner J; Caltová K; Cervinka M; Rezáč A; Spaček J; Skapinec P
    Klin Onkol; 2012; 25(6):457-63. PubMed ID: 23301649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of ATP-binding Cassette Proteins Pgp, MRP1, and MRP3 in Malignant and Benign Ovarian Lesions].
    Sedláková I; Laco J; Tošner J; Špaček J
    Klin Onkol; 2016; 29(5):358-363. PubMed ID: 27739315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of MRP1, LRP and Pgp in breast carcinoma patients treated with preoperative chemotherapy.
    Rudas M; Filipits M; Taucher S; Stranzl T; Steger GG; Jakesz R; Pirker R; Pohl G
    Breast Cancer Res Treat; 2003 Sep; 81(2):149-57. PubMed ID: 14572157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug resistance-associated biomarkers PGP, GST-pi, Topo-II and LRP as prognostic factors in primary ovarian carcinoma.
    Lu D; Shi HC; Wang ZX; Gu XW; Zeng YJ
    Br J Biomed Sci; 2011; 68(2):69-74. PubMed ID: 21706917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression and prognostic value of the drug resistance markers P-gp, Mrp1, Mrp2, and Lrp in ovarian carcinoma].
    Katsaros D; Fracchioli S; Arts HJ; de Vries EG; Danese S; Richiardi G; Arisio R; Gordini G; Van der Zee AG; Suurmeijer AJ; Massobrio M
    Minerva Ginecol; 1999 Dec; 51(12):463-70. PubMed ID: 10767994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug resistance-associated marker Lrp for prediction of response to chemotherapy and prognoses in advanced ovarian carcinoma.
    Izquierdo MA; van der Zee AG; Vermorken JB; van der Valk P; Beliën JA; Giaccone G; Scheffer GL; Flens MJ; Pinedo HM; Kenemans P
    J Natl Cancer Inst; 1995 Aug; 87(16):1230-7. PubMed ID: 7563169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of proteins associated with multidrug resistance and resistance to chemotherapy in lung cancer].
    Paredes Lario A; Blanco García C; Echenique Elizondo M; Lobo C
    Arch Bronconeumol; 2007 Sep; 43(9):479-84. PubMed ID: 17919413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug resistance-associated markers P-glycoprotein, multidrug resistance-associated protein 1, multidrug resistance-associated protein 2, and lung resistance protein as prognostic factors in ovarian carcinoma.
    Arts HJ; Katsaros D; de Vries EG; Massobrio M; Genta F; Danese S; Arisio R; Scheper RJ; Kool M; Scheffer GL; Willemse PH; van der Zee AG; Suurmeijer AJ
    Clin Cancer Res; 1999 Oct; 5(10):2798-805. PubMed ID: 10537344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of drug resistance proteins Pgp, MRP1, MRP3, MRP5 and GST-pi in human glioma.
    Calatozzolo C; Gelati M; Ciusani E; Sciacca FL; Pollo B; Cajola L; Marras C; Silvani A; Vitellaro-Zuccarello L; Croci D; Boiardi A; Salmaggi A
    J Neurooncol; 2005 Sep; 74(2):113-21. PubMed ID: 16193381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
    Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
    Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of chemotherapy response with P-glycoprotein, multidrug resistance-related protein-1, and lung resistance-related protein expression in untreated small cell lung cancer.
    Yeh JJ; Hsu NY; Hsu WH; Tsai CH; Lin CC; Liang JA
    Lung; 2005; 183(3):177-83. PubMed ID: 16078039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of expression of MRP1, BCRP, LRP and ERCC1 with outcome of patients with locally advanced non-small cell lung cancer who received neoadjuvant chemotherapy.
    Li J; Li ZN; Yu LC; Bao QL; Wu JR; Shi SB; Li XQ
    Lung Cancer; 2010 Jul; 69(1):116-22. PubMed ID: 19875192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P-glycoprotein (PGP), lung resistance-related protein (LRP) and multidrug resistance-associated protein (MRP) expression in acute promyelocytic leukaemia.
    Michieli M; Damiani D; Ermacora A; Geromin A; Michelutti A; Masolini P; Baccarani M
    Br J Haematol; 2000 Mar; 108(4):703-9. PubMed ID: 10792272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of multidrug resistance proteins, P-gp, MRP1 and LRP, in soft tissue sarcomas analysed according to their histological type and grade.
    Komdeur R; Plaat BE; van der Graaf WT; Hoekstra HJ; Hollema H; van den Berg E; Zwart N; Scheper RJ; Molenaar WM
    Eur J Cancer; 2003 May; 39(7):909-16. PubMed ID: 12706359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATP-binding cassette superfamily transporter gene expression in human primary ovarian carcinoma.
    Ohishi Y; Oda Y; Uchiumi T; Kobayashi H; Hirakawa T; Miyamoto S; Kinukawa N; Nakano H; Kuwano M; Tsuneyoshi M
    Clin Cancer Res; 2002 Dec; 8(12):3767-75. PubMed ID: 12473588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of MRP1, BCRP, LRP, and ERCC1 in advanced non-small-cell lung cancer: correlation with response to chemotherapy and survival.
    Li J; Li ZN; Du YJ; Li XQ; Bao QL; Chen P
    Clin Lung Cancer; 2009 Nov; 10(6):414-21. PubMed ID: 19900859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug resistance features and S-phase fraction as possible determinants for drug response in a panel of human ovarian cancer xenografts.
    Kolfschoten GM; Hulscher TM; Pinedo HM; Boven E
    Br J Cancer; 2000 Oct; 83(7):921-7. PubMed ID: 10970695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.